References
- Holloway R H, Dent J. Pathophysiology of gastroesophageal reflux. Gastroenterol Clin North Am 1990; 19: 517–34
- Joelsson B, Johnsson F. Heartburn–the acid test. Gut 1989; 30: 1523–5
- Mattioli S, Pilotti V, Spangaro M, Grigioni W F, Zannoli R, Felice V, et al. Reliability of 24-hour home esophageal pH monitoring in diagnosis of gastroesophageal reflux. Dig Dis Sci 1989; 34: 71–8
- Moss H A, Washington N, Greaves J L, Wilson C G. Anti-reflux agents: stratification or flotation?. Eur J Gastroenterol Hepatol 1990; 2: 45–51
- Washington N, Wilson C G, Greaves J L, Danneskiold-Samsoe P. An investigation into the floating behaviour of a pectin-containing anti-reflux formulation (FF5005) by means of gamma scintigraphy. Scand J Gastroenterol 1988; 23: 920–4
- Havelund T, Aalykke C, Rasmussen L. Efficacy of a pectin-based anti-reflux agent on acid reflux and recurrence of symptoms and oesophagitis in gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol., in press
- Elton R A, Tiplady B. Mild, moderate, severe–the statistical analysis of short ordinal scales. Neuropharmacology 1980; 19: 1239
- Tytgat GNJ, Nicolai J J, Reman FC. Efficacy of different doses of cimetidine in the treatment of reflux esophagitis. A review of three large, double-blind, controlled trials. Gastroenterology 1990; 99: 629–34
- Green JRB. Is there such an entity as mild oesophagitis? Eur J. Clin Res 1993; 4: 29–34
- Kuster E, Ros E, Toledo-Pimentel V, Pujol A, Bordas J M, Grande L, et al. Predictive factors of the long term outcome in gastro-oesophageal reflux disease: six year follow up of 107 patients. Gut 1994; 35: 8–14
- Stanciu C, Bennett J R. Alginate\antacid in the reduction of gastro-oesophageal reflux. Lancet 1974; 1: 109–11
- Lanza F L, Smith V, Page-Castell J A, Castell D O. Effectiveness of foaming antacid in relieving induced heartburn. Soum Med J 1986; 79: 327–30
- Barnardo D E, Lancaster-Smith M, Strickland I D, Wright J T. A double-blind controlled trial of 'Gaviscon' in patients with symptomatic gastro-oesophageal reflux. Curr Med Res Opin 1975; 3: 388–91
- McHardy G. A multicentric, randomized clinical trial of Gaviscon in reflux esophagitis. South Med J 1978; 71: 16–21, Suppl 1
- Poynard Y. French Co-operative Study Group. Relapse rate of patients after healing of oesophagitis–a prospective study of alginate as self-care treatment for 6 months. Aliment Pharmacol Ther 1993; 7: 385–92